chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: UNK
Symptoms: Musculoskeletal disorder, Posture abnormal, Transient ischaemic attack
Clinical narrative: He got his vaccine, just didn't feel right, was light headed, just did not feel right.  His right arm started acting weird, and his right leg would collapse every once in a while.  He probably should have told the doctors that his arm wasn't working right, but they did not check his arm.  They ran cancer tests on him, and determined that he did not have any.  They ignored what he needed to be seen for.  He did not go back, and his arm was still acting weird, and while he was driving home he felt really strange.  he got home and was watching TV and collapsed over to his right side, and felt like his brain was not with him.  His right arm would not work, but he could walk.  He called a friend and asked for help who called paramedics and said that he was slurring his words.   He went to a hospital and they diagnosed him with a stroke.  They did a brain scan on him and told him that he had a few mini-strokes before the major one.  They put him on medicines which he took for a while and then stopped.  He had a doctor that he was seeing, and would not give him any pain medicines to be able to sleep.  He wants him to do a colon cancer tests and all sorts of weird and strange tests, and he does not want to have them done unless he has an issue.   He continues to not be able to think, really light headed, days where he is dizzy.  He has fallen a few times and does drive as he is an over the road truck driver, but if he doesn't feel like it he does not.    He considered himself healthy prior to the vaccine, and ran and other issues, and does not feel healthy anymore.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 44.0
Sex: M
Vaccine: FLU4, HEP, MMR
Symptoms: Pruritus, Rash, Rash macular
Clinical narrative: Patient had allergic reaction in office after waiting his 15 mins. Patient was checking out and informed he was noticing a rash and red blotches on his arms. Patient was brought back to the clinic and he explined the rash on his arms was itchy and he was feeling itchy and tingling in his face. Patient denied shortness of breath, difficulty swallowing, and facial swelling.  Patient was given 50ml of benadryl IM and waited an additional 20 minutes. After 20 minutes patient was notably improved and still had no complaints of difficulty breathing and swallowing.
Age: 27.0
Sex: M
Vaccine: FLU4, HEP, HEPA, HPV9
Symptoms: Underdose
Clinical narrative: A pediatric dose of HepB was accidentally administered to client instead of an adult dose. Client was contacted and informed of the incident. Staff also explained that because it was a pediatric dose, it would be considered invalid and he would need to receive an adult dose of HepB to complete the series. Staff scheduled client an appointment on 1/18/23 and an adult dose of HepB was administered.  Second, the HPV9 was pulled from the inventory and it should have been taken from the private vaccine inventory.  Due to client's age, he does not qualify for program. This dose will be replaced with private pay and private vaccine loss report will be completed by my supervisor.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Exposure to SARS-CoV-2, Jaw disorder, SARS-CoV-2 test, Sinusitis
Clinical narrative: I started off having issues with my left jaw, so I did the saltwater gargle and that didn't help long term. I made an appointment because I was having a sinus issue or so I thought. After the appointment I decided to dig deeper. Initially I thought it was a sinus headache, but I was wrong. I did take a home test after finding out my son was positive for COVID-19. I isolated and kept taking the medication I was given to treat what I that was a sinus infection.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anaemia, Anaemia of chronic disease, Anticoagulant therapy, Blood culture
Clinical narrative: Patient is a 77 y.o. male patient of PRIVATE, MD with history of recent PEA arrest with cardiogenic shock, NSTEMI, chronic HFpEF, PAF on Eliquis, CAD s/p PCI, s/p ICD, HTN, HLD,COPD with chronic hypoxemic respiratory failure on home 02 and recent intubation, DM2, GERD, Normocytic anemia, Nicotine Dependence, and weakness with deconditioning, who presents with worsening shortness of breath from baseline.    Acute on Chronic Respiratory Failure with hypoxia Acute COPD Exacerbation COVID-19 Infection Secondary to COPD and recent PEA CXR with no infiltrate, nodule, or effusion.  Chronic lung markings. Continuous pulse ox with nasal cannula oxygen.  Reviewed down to 2 L O2 which is his baseline Continue bronchodilators as ordered Vaccinated with booster Symptoms onset 12/13/2022, positive test date 12/15/2022 tested positive again on 12/21 ID recommendation noted.  Continue remdesivir for 5 days and Decadron for 10 days.  Monitor daily CMP Anticoagulation: Home Eliquis Consider discontinuation of isolation 12/23/22 after completion 10 days isolation from symptom onset 12/13   Acute on Chronic Systolic Congestive heart failure  Paroxysmal A. fib Recent ECHO from 11/2022 showed Moderately severe LV cavity enlargement with severe global systolic dysfunction; EF 15-20%. indeterminate study for diastolic function. IV lasix 40 twice daily discontinued, euvolemic on exam  Strict I&Os Fluid restriction Continue Eliquis Cardiology and palliative cardiology and palliative care following.  Recommendations noted.  Net IO Since Admission: -6,767.99 mL [12/30/22 0736]   Sepsis without organ dysfunction -resolved now Secondary to  COVID-19  & POA:  Presented with tachycardia and tachypnea. Hemodynamically stable, not requiring vasopressors received breathing treatments in ED Workup: COVID-19 positive, influenza A/B negative, and BC/UC pending Holding antibiotics given viral etiology at this time   DM2 Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180  Chronic Anemia Secondary to anemia of chronic disease  Baseline hemoglobin 9.0 Admission hemoglobin 9.0 No signs of overt bleeding Trend CBC daily, and Q72h Type and screen if indicated Transfuse for hbg < 7   Other chronic medical conditions: Continue all home meds except stated above or contraindicated. ? Recent PEA arrest with cardiogenic shock ? NSTEMI ? CAD s/p PCI ? S/p ICD ? HTN ? HLD ? GERD ? Nicotine Dependence ? Weakness with deconditioning
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure acute, Cardiac failure congestive, Chest X-ray abnormal, Chronic obstructive pulmonary disease
Clinical narrative: Patient is a 77 y.o. male patient of PRIVATE, MD with history of recent PEA arrest with cardiogenic shock, NSTEMI, chronic HFpEF, PAF on Eliquis, CAD s/p PCI, s/p ICD, HTN, HLD,COPD with chronic hypoxemic respiratory failure on home 02 and recent intubation, DM2, GERD, Normocytic anemia, Nicotine Dependence, and weakness with deconditioning, who presents with worsening shortness of breath from baseline.    Acute on Chronic Respiratory Failure with hypoxia Acute COPD Exacerbation COVID-19 Infection Secondary to COPD and recent PEA CXR with no infiltrate, nodule, or effusion.  Chronic lung markings. Continuous pulse ox with nasal cannula oxygen.  Reviewed down to 2 L O2 which is his baseline Continue bronchodilators as ordered Vaccinated with booster Symptoms onset 12/13/2022, positive test date 12/15/2022 tested positive again on 12/21 ID recommendation noted.  Continue remdesivir for 5 days and Decadron for 10 days.  Monitor daily CMP Anticoagulation: Home Eliquis Consider discontinuation of isolation 12/23/22 after completion 10 days isolation from symptom onset 12/13   Acute on Chronic Systolic Congestive heart failure  Paroxysmal A. fib Recent ECHO from 11/2022 showed Moderately severe LV cavity enlargement with severe global systolic dysfunction; EF 15-20%. indeterminate study for diastolic function. IV lasix 40 twice daily discontinued, euvolemic on exam  Strict I&Os Fluid restriction Continue Eliquis Cardiology and palliative cardiology and palliative care following.  Recommendations noted.  Net IO Since Admission: -6,767.99 mL [12/30/22 0736]   Sepsis without organ dysfunction -resolved now Secondary to  COVID-19  & POA:  Presented with tachycardia and tachypnea. Hemodynamically stable, not requiring vasopressors received breathing treatments in ED Workup: COVID-19 positive, influenza A/B negative, and BC/UC pending Holding antibiotics given viral etiology at this time   DM2 Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180  Chronic Anemia Secondary to anemia of chronic disease  Baseline hemoglobin 9.0 Admission hemoglobin 9.0 No signs of overt bleeding Trend CBC daily, and Q72h Type and screen if indicated Transfuse for hbg < 7   Other chronic medical conditions: Continue all home meds except stated above or contraindicated. ? Recent PEA arrest with cardiogenic shock ? NSTEMI ? CAD s/p PCI ? S/p ICD ? HTN ? HLD ? GERD ? Nicotine Dependence ? Weakness with deconditioning
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Culture urine, Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: Patient is a 77 y.o. male patient of PRIVATE, MD with history of recent PEA arrest with cardiogenic shock, NSTEMI, chronic HFpEF, PAF on Eliquis, CAD s/p PCI, s/p ICD, HTN, HLD,COPD with chronic hypoxemic respiratory failure on home 02 and recent intubation, DM2, GERD, Normocytic anemia, Nicotine Dependence, and weakness with deconditioning, who presents with worsening shortness of breath from baseline.    Acute on Chronic Respiratory Failure with hypoxia Acute COPD Exacerbation COVID-19 Infection Secondary to COPD and recent PEA CXR with no infiltrate, nodule, or effusion.  Chronic lung markings. Continuous pulse ox with nasal cannula oxygen.  Reviewed down to 2 L O2 which is his baseline Continue bronchodilators as ordered Vaccinated with booster Symptoms onset 12/13/2022, positive test date 12/15/2022 tested positive again on 12/21 ID recommendation noted.  Continue remdesivir for 5 days and Decadron for 10 days.  Monitor daily CMP Anticoagulation: Home Eliquis Consider discontinuation of isolation 12/23/22 after completion 10 days isolation from symptom onset 12/13   Acute on Chronic Systolic Congestive heart failure  Paroxysmal A. fib Recent ECHO from 11/2022 showed Moderately severe LV cavity enlargement with severe global systolic dysfunction; EF 15-20%. indeterminate study for diastolic function. IV lasix 40 twice daily discontinued, euvolemic on exam  Strict I&Os Fluid restriction Continue Eliquis Cardiology and palliative cardiology and palliative care following.  Recommendations noted.  Net IO Since Admission: -6,767.99 mL [12/30/22 0736]   Sepsis without organ dysfunction -resolved now Secondary to  COVID-19  & POA:  Presented with tachycardia and tachypnea. Hemodynamically stable, not requiring vasopressors received breathing treatments in ED Workup: COVID-19 positive, influenza A/B negative, and BC/UC pending Holding antibiotics given viral etiology at this time   DM2 Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180  Chronic Anemia Secondary to anemia of chronic disease  Baseline hemoglobin 9.0 Admission hemoglobin 9.0 No signs of overt bleeding Trend CBC daily, and Q72h Type and screen if indicated Transfuse for hbg < 7   Other chronic medical conditions: Continue all home meds except stated above or contraindicated. ? Recent PEA arrest with cardiogenic shock ? NSTEMI ? CAD s/p PCI ? S/p ICD ? HTN ? HLD ? GERD ? Nicotine Dependence ? Weakness with deconditioning
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fluid intake restriction, Influenza A virus test negative, Influenza B virus test, Left ventricular enlargement, Left ventricular failure
Clinical narrative: Patient is a 77 y.o. male patient of PRIVATE, MD with history of recent PEA arrest with cardiogenic shock, NSTEMI, chronic HFpEF, PAF on Eliquis, CAD s/p PCI, s/p ICD, HTN, HLD,COPD with chronic hypoxemic respiratory failure on home 02 and recent intubation, DM2, GERD, Normocytic anemia, Nicotine Dependence, and weakness with deconditioning, who presents with worsening shortness of breath from baseline.    Acute on Chronic Respiratory Failure with hypoxia Acute COPD Exacerbation COVID-19 Infection Secondary to COPD and recent PEA CXR with no infiltrate, nodule, or effusion.  Chronic lung markings. Continuous pulse ox with nasal cannula oxygen.  Reviewed down to 2 L O2 which is his baseline Continue bronchodilators as ordered Vaccinated with booster Symptoms onset 12/13/2022, positive test date 12/15/2022 tested positive again on 12/21 ID recommendation noted.  Continue remdesivir for 5 days and Decadron for 10 days.  Monitor daily CMP Anticoagulation: Home Eliquis Consider discontinuation of isolation 12/23/22 after completion 10 days isolation from symptom onset 12/13   Acute on Chronic Systolic Congestive heart failure  Paroxysmal A. fib Recent ECHO from 11/2022 showed Moderately severe LV cavity enlargement with severe global systolic dysfunction; EF 15-20%. indeterminate study for diastolic function. IV lasix 40 twice daily discontinued, euvolemic on exam  Strict I&Os Fluid restriction Continue Eliquis Cardiology and palliative cardiology and palliative care following.  Recommendations noted.  Net IO Since Admission: -6,767.99 mL [12/30/22 0736]   Sepsis without organ dysfunction -resolved now Secondary to  COVID-19  & POA:  Presented with tachycardia and tachypnea. Hemodynamically stable, not requiring vasopressors received breathing treatments in ED Workup: COVID-19 positive, influenza A/B negative, and BC/UC pending Holding antibiotics given viral etiology at this time   DM2 Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180  Chronic Anemia Secondary to anemia of chronic disease  Baseline hemoglobin 9.0 Admission hemoglobin 9.0 No signs of overt bleeding Trend CBC daily, and Q72h Type and screen if indicated Transfuse for hbg < 7   Other chronic medical conditions: Continue all home meds except stated above or contraindicated. ? Recent PEA arrest with cardiogenic shock ? NSTEMI ? CAD s/p PCI ? S/p ICD ? HTN ? HLD ? GERD ? Nicotine Dependence ? Weakness with deconditioning
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Lung disorder, Malaise, Pulseless electrical activity, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 77 y.o. male patient of PRIVATE, MD with history of recent PEA arrest with cardiogenic shock, NSTEMI, chronic HFpEF, PAF on Eliquis, CAD s/p PCI, s/p ICD, HTN, HLD,COPD with chronic hypoxemic respiratory failure on home 02 and recent intubation, DM2, GERD, Normocytic anemia, Nicotine Dependence, and weakness with deconditioning, who presents with worsening shortness of breath from baseline.    Acute on Chronic Respiratory Failure with hypoxia Acute COPD Exacerbation COVID-19 Infection Secondary to COPD and recent PEA CXR with no infiltrate, nodule, or effusion.  Chronic lung markings. Continuous pulse ox with nasal cannula oxygen.  Reviewed down to 2 L O2 which is his baseline Continue bronchodilators as ordered Vaccinated with booster Symptoms onset 12/13/2022, positive test date 12/15/2022 tested positive again on 12/21 ID recommendation noted.  Continue remdesivir for 5 days and Decadron for 10 days.  Monitor daily CMP Anticoagulation: Home Eliquis Consider discontinuation of isolation 12/23/22 after completion 10 days isolation from symptom onset 12/13   Acute on Chronic Systolic Congestive heart failure  Paroxysmal A. fib Recent ECHO from 11/2022 showed Moderately severe LV cavity enlargement with severe global systolic dysfunction; EF 15-20%. indeterminate study for diastolic function. IV lasix 40 twice daily discontinued, euvolemic on exam  Strict I&Os Fluid restriction Continue Eliquis Cardiology and palliative cardiology and palliative care following.  Recommendations noted.  Net IO Since Admission: -6,767.99 mL [12/30/22 0736]   Sepsis without organ dysfunction -resolved now Secondary to  COVID-19  & POA:  Presented with tachycardia and tachypnea. Hemodynamically stable, not requiring vasopressors received breathing treatments in ED Workup: COVID-19 positive, influenza A/B negative, and BC/UC pending Holding antibiotics given viral etiology at this time   DM2 Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180  Chronic Anemia Secondary to anemia of chronic disease  Baseline hemoglobin 9.0 Admission hemoglobin 9.0 No signs of overt bleeding Trend CBC daily, and Q72h Type and screen if indicated Transfuse for hbg < 7   Other chronic medical conditions: Continue all home meds except stated above or contraindicated. ? Recent PEA arrest with cardiogenic shock ? NSTEMI ? CAD s/p PCI ? S/p ICD ? HTN ? HLD ? GERD ? Nicotine Dependence ? Weakness with deconditioning
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Systolic dysfunction, Tachycardia, Tachypnoea
Clinical narrative: Patient is a 77 y.o. male patient of PRIVATE, MD with history of recent PEA arrest with cardiogenic shock, NSTEMI, chronic HFpEF, PAF on Eliquis, CAD s/p PCI, s/p ICD, HTN, HLD,COPD with chronic hypoxemic respiratory failure on home 02 and recent intubation, DM2, GERD, Normocytic anemia, Nicotine Dependence, and weakness with deconditioning, who presents with worsening shortness of breath from baseline.    Acute on Chronic Respiratory Failure with hypoxia Acute COPD Exacerbation COVID-19 Infection Secondary to COPD and recent PEA CXR with no infiltrate, nodule, or effusion.  Chronic lung markings. Continuous pulse ox with nasal cannula oxygen.  Reviewed down to 2 L O2 which is his baseline Continue bronchodilators as ordered Vaccinated with booster Symptoms onset 12/13/2022, positive test date 12/15/2022 tested positive again on 12/21 ID recommendation noted.  Continue remdesivir for 5 days and Decadron for 10 days.  Monitor daily CMP Anticoagulation: Home Eliquis Consider discontinuation of isolation 12/23/22 after completion 10 days isolation from symptom onset 12/13   Acute on Chronic Systolic Congestive heart failure  Paroxysmal A. fib Recent ECHO from 11/2022 showed Moderately severe LV cavity enlargement with severe global systolic dysfunction; EF 15-20%. indeterminate study for diastolic function. IV lasix 40 twice daily discontinued, euvolemic on exam  Strict I&Os Fluid restriction Continue Eliquis Cardiology and palliative cardiology and palliative care following.  Recommendations noted.  Net IO Since Admission: -6,767.99 mL [12/30/22 0736]   Sepsis without organ dysfunction -resolved now Secondary to  COVID-19  & POA:  Presented with tachycardia and tachypnea. Hemodynamically stable, not requiring vasopressors received breathing treatments in ED Workup: COVID-19 positive, influenza A/B negative, and BC/UC pending Holding antibiotics given viral etiology at this time   DM2 Hold home oral medication, Diet Special; Diabetic, Cardiac; Carbohydrate Consistent 60g/meal (1500-2000 kCal equivalent) diet, sensitive SSI + BG checks ACHS, hypoglycemic protocol, and target BG 140-180  Chronic Anemia Secondary to anemia of chronic disease  Baseline hemoglobin 9.0 Admission hemoglobin 9.0 No signs of overt bleeding Trend CBC daily, and Q72h Type and screen if indicated Transfuse for hbg < 7   Other chronic medical conditions: Continue all home meds except stated above or contraindicated. ? Recent PEA arrest with cardiogenic shock ? NSTEMI ? CAD s/p PCI ? S/p ICD ? HTN ? HLD ? GERD ? Nicotine Dependence ? Weakness with deconditioning
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: I was having very hard chest pains. I had to keep compressions on my chest, using heat to relieve the pain. I emailed my doctor letting her know about the adverse event.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Depression, Hemiparesis, Intensive care, Ischaemic stroke, Laboratory test
Clinical narrative: He had an ischemic stroke on March 31, 2022 and was rushed to the emergency room. They administered a TPA and they flushed the residue through the groin. He was admitted into ICU for a week and in the hospital for another week. He went to rehab after leaving the hospital for 2 weeks. He was prescribed PRADAXA and KEPPRA and initially he was given SEROQUEL for depression but taken off. He has recovered very well other than his speech. He is still currently still going to occupational and speech therapy. He also still has weakness on the right side since he had the stroke in the left brain area.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Speech disorder
Clinical narrative: He had an ischemic stroke on March 31, 2022 and was rushed to the emergency room. They administered a TPA and they flushed the residue through the groin. He was admitted into ICU for a week and in the hospital for another week. He went to rehab after leaving the hospital for 2 weeks. He was prescribed PRADAXA and KEPPRA and initially he was given SEROQUEL for depression but taken off. He has recovered very well other than his speech. He is still currently still going to occupational and speech therapy. He also still has weakness on the right side since he had the stroke in the left brain area.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chronic kidney disease, Fall, Gastrointestinal haemorrhage, Hypoxia
Clinical narrative: Hospitalization 1/22/22-1/28/22 weakness, fall x 2, productive cough,  hypoxia, CKD III, GI bleed,
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough
Clinical narrative: Hospitalization 1/22/22-1/28/22 weakness, fall x 2, productive cough,  hypoxia, CKD III, GI bleed,
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Developed Covid had sore throat no fever little congestion.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Alopecia, Anosmia, Anxiety, Catatonia
Clinical narrative: 62 yr. old male  took no prescriptions or drugs prior, yearly received flu shots, had a high technical job, very active and healthy. 10/2021 Patient had COVID, received the 4 anti-body shots 11/21 till 3/22 experienced sever hair loss, taste and smell. Patient was a employee for Technology company and required to receive the vax.  J&J was not available at the time Patient received the 1ST Moderna vax on 1/20/22; 90 days after anti-body shots as recommended by medical staff.   At the time of injection, he experienced pain in left arm, 4x4 red swollen area, for about 4 days.  Within a week had pain across back of the head, heaviness in chest and cognitive decline issues, lack of concentration. 2/17/22 Patient received 2nd Moderna vax.  In addition to the prior symptom's, patient experienced sever insomnia, sever anxiety and depression, and erectile disfunction. 6 weeks later admitted to the hospital. After a PCP visit, patient was admitted to hospital with suicidal ideation severe anxiety.  NO prior family or personal history of mental health.   4/1-4/18/2022 hospitalized and discharged with no meds or follow-up doctor or therapy appointments. 4/29/22 re-admitted to hospital, via ambulance, presenting like Parkinson, tremors, unable to walk, lack of communication, some delirium.  Noted as a possible drug withdrawal from previous visit.  Took off controlled substances too quickly.  Diagnosed with catatonia, severe depression and anxiety.  5/13/22 transferred to another hospital, with a psych wing, for treatment and began ECT sessions.  Discharged from hospital 6/8/22 with meds and future appointment with a therapist and psychiatrist and follow up OP ECT sessions for another month or so.  Continued therapist and psych Dr appointments to this day.  8/2022 consult with Neurological Institute.  Had MRI and EEG  both unremarkable. Patient continues on 4 medications and under weekly therapist and 2x/month doctor's care. Some improvement, not much.   Patient is currently on LTD from his job as of Sept 27/2022
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Cognitive disorder, Communication disorder, Computerised tomogram, Delirium
Clinical narrative: 62 yr. old male  took no prescriptions or drugs prior, yearly received flu shots, had a high technical job, very active and healthy. 10/2021 Patient had COVID, received the 4 anti-body shots 11/21 till 3/22 experienced sever hair loss, taste and smell. Patient was a employee for Technology company and required to receive the vax.  J&J was not available at the time Patient received the 1ST Moderna vax on 1/20/22; 90 days after anti-body shots as recommended by medical staff.   At the time of injection, he experienced pain in left arm, 4x4 red swollen area, for about 4 days.  Within a week had pain across back of the head, heaviness in chest and cognitive decline issues, lack of concentration. 2/17/22 Patient received 2nd Moderna vax.  In addition to the prior symptom's, patient experienced sever insomnia, sever anxiety and depression, and erectile disfunction. 6 weeks later admitted to the hospital. After a PCP visit, patient was admitted to hospital with suicidal ideation severe anxiety.  NO prior family or personal history of mental health.   4/1-4/18/2022 hospitalized and discharged with no meds or follow-up doctor or therapy appointments. 4/29/22 re-admitted to hospital, via ambulance, presenting like Parkinson, tremors, unable to walk, lack of communication, some delirium.  Noted as a possible drug withdrawal from previous visit.  Took off controlled substances too quickly.  Diagnosed with catatonia, severe depression and anxiety.  5/13/22 transferred to another hospital, with a psych wing, for treatment and began ECT sessions.  Discharged from hospital 6/8/22 with meds and future appointment with a therapist and psychiatrist and follow up OP ECT sessions for another month or so.  Continued therapist and psych Dr appointments to this day.  8/2022 consult with Neurological Institute.  Had MRI and EEG  both unremarkable. Patient continues on 4 medications and under weekly therapist and 2x/month doctor's care. Some improvement, not much.   Patient is currently on LTD from his job as of Sept 27/2022
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Depression, Disability, Disturbance in attention, Electroconvulsive therapy, Electroencephalogram normal
Clinical narrative: 62 yr. old male  took no prescriptions or drugs prior, yearly received flu shots, had a high technical job, very active and healthy. 10/2021 Patient had COVID, received the 4 anti-body shots 11/21 till 3/22 experienced sever hair loss, taste and smell. Patient was a employee for Technology company and required to receive the vax.  J&J was not available at the time Patient received the 1ST Moderna vax on 1/20/22; 90 days after anti-body shots as recommended by medical staff.   At the time of injection, he experienced pain in left arm, 4x4 red swollen area, for about 4 days.  Within a week had pain across back of the head, heaviness in chest and cognitive decline issues, lack of concentration. 2/17/22 Patient received 2nd Moderna vax.  In addition to the prior symptom's, patient experienced sever insomnia, sever anxiety and depression, and erectile disfunction. 6 weeks later admitted to the hospital. After a PCP visit, patient was admitted to hospital with suicidal ideation severe anxiety.  NO prior family or personal history of mental health.   4/1-4/18/2022 hospitalized and discharged with no meds or follow-up doctor or therapy appointments. 4/29/22 re-admitted to hospital, via ambulance, presenting like Parkinson, tremors, unable to walk, lack of communication, some delirium.  Noted as a possible drug withdrawal from previous visit.  Took off controlled substances too quickly.  Diagnosed with catatonia, severe depression and anxiety.  5/13/22 transferred to another hospital, with a psych wing, for treatment and began ECT sessions.  Discharged from hospital 6/8/22 with meds and future appointment with a therapist and psychiatrist and follow up OP ECT sessions for another month or so.  Continued therapist and psych Dr appointments to this day.  8/2022 consult with Neurological Institute.  Had MRI and EEG  both unremarkable. Patient continues on 4 medications and under weekly therapist and 2x/month doctor's care. Some improvement, not much.   Patient is currently on LTD from his job as of Sept 27/2022
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erectile dysfunction, Erythema, Gait inability, Headache, Insomnia
Clinical narrative: 62 yr. old male  took no prescriptions or drugs prior, yearly received flu shots, had a high technical job, very active and healthy. 10/2021 Patient had COVID, received the 4 anti-body shots 11/21 till 3/22 experienced sever hair loss, taste and smell. Patient was a employee for Technology company and required to receive the vax.  J&J was not available at the time Patient received the 1ST Moderna vax on 1/20/22; 90 days after anti-body shots as recommended by medical staff.   At the time of injection, he experienced pain in left arm, 4x4 red swollen area, for about 4 days.  Within a week had pain across back of the head, heaviness in chest and cognitive decline issues, lack of concentration. 2/17/22 Patient received 2nd Moderna vax.  In addition to the prior symptom's, patient experienced sever insomnia, sever anxiety and depression, and erectile disfunction. 6 weeks later admitted to the hospital. After a PCP visit, patient was admitted to hospital with suicidal ideation severe anxiety.  NO prior family or personal history of mental health.   4/1-4/18/2022 hospitalized and discharged with no meds or follow-up doctor or therapy appointments. 4/29/22 re-admitted to hospital, via ambulance, presenting like Parkinson, tremors, unable to walk, lack of communication, some delirium.  Noted as a possible drug withdrawal from previous visit.  Took off controlled substances too quickly.  Diagnosed with catatonia, severe depression and anxiety.  5/13/22 transferred to another hospital, with a psych wing, for treatment and began ECT sessions.  Discharged from hospital 6/8/22 with meds and future appointment with a therapist and psychiatrist and follow up OP ECT sessions for another month or so.  Continued therapist and psych Dr appointments to this day.  8/2022 consult with Neurological Institute.  Had MRI and EEG  both unremarkable. Patient continues on 4 medications and under weekly therapist and 2x/month doctor's care. Some improvement, not much.   Patient is currently on LTD from his job as of Sept 27/2022
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head normal, Pain in extremity, Parkinson's disease, Peripheral swelling, Suicidal ideation
Clinical narrative: 62 yr. old male  took no prescriptions or drugs prior, yearly received flu shots, had a high technical job, very active and healthy. 10/2021 Patient had COVID, received the 4 anti-body shots 11/21 till 3/22 experienced sever hair loss, taste and smell. Patient was a employee for Technology company and required to receive the vax.  J&J was not available at the time Patient received the 1ST Moderna vax on 1/20/22; 90 days after anti-body shots as recommended by medical staff.   At the time of injection, he experienced pain in left arm, 4x4 red swollen area, for about 4 days.  Within a week had pain across back of the head, heaviness in chest and cognitive decline issues, lack of concentration. 2/17/22 Patient received 2nd Moderna vax.  In addition to the prior symptom's, patient experienced sever insomnia, sever anxiety and depression, and erectile disfunction. 6 weeks later admitted to the hospital. After a PCP visit, patient was admitted to hospital with suicidal ideation severe anxiety.  NO prior family or personal history of mental health.   4/1-4/18/2022 hospitalized and discharged with no meds or follow-up doctor or therapy appointments. 4/29/22 re-admitted to hospital, via ambulance, presenting like Parkinson, tremors, unable to walk, lack of communication, some delirium.  Noted as a possible drug withdrawal from previous visit.  Took off controlled substances too quickly.  Diagnosed with catatonia, severe depression and anxiety.  5/13/22 transferred to another hospital, with a psych wing, for treatment and began ECT sessions.  Discharged from hospital 6/8/22 with meds and future appointment with a therapist and psychiatrist and follow up OP ECT sessions for another month or so.  Continued therapist and psych Dr appointments to this day.  8/2022 consult with Neurological Institute.  Had MRI and EEG  both unremarkable. Patient continues on 4 medications and under weekly therapist and 2x/month doctor's care. Some improvement, not much.   Patient is currently on LTD from his job as of Sept 27/2022
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: 62 yr. old male  took no prescriptions or drugs prior, yearly received flu shots, had a high technical job, very active and healthy. 10/2021 Patient had COVID, received the 4 anti-body shots 11/21 till 3/22 experienced sever hair loss, taste and smell. Patient was a employee for Technology company and required to receive the vax.  J&J was not available at the time Patient received the 1ST Moderna vax on 1/20/22; 90 days after anti-body shots as recommended by medical staff.   At the time of injection, he experienced pain in left arm, 4x4 red swollen area, for about 4 days.  Within a week had pain across back of the head, heaviness in chest and cognitive decline issues, lack of concentration. 2/17/22 Patient received 2nd Moderna vax.  In addition to the prior symptom's, patient experienced sever insomnia, sever anxiety and depression, and erectile disfunction. 6 weeks later admitted to the hospital. After a PCP visit, patient was admitted to hospital with suicidal ideation severe anxiety.  NO prior family or personal history of mental health.   4/1-4/18/2022 hospitalized and discharged with no meds or follow-up doctor or therapy appointments. 4/29/22 re-admitted to hospital, via ambulance, presenting like Parkinson, tremors, unable to walk, lack of communication, some delirium.  Noted as a possible drug withdrawal from previous visit.  Took off controlled substances too quickly.  Diagnosed with catatonia, severe depression and anxiety.  5/13/22 transferred to another hospital, with a psych wing, for treatment and began ECT sessions.  Discharged from hospital 6/8/22 with meds and future appointment with a therapist and psychiatrist and follow up OP ECT sessions for another month or so.  Continued therapist and psych Dr appointments to this day.  8/2022 consult with Neurological Institute.  Had MRI and EEG  both unremarkable. Patient continues on 4 medications and under weekly therapist and 2x/month doctor's care. Some improvement, not much.   Patient is currently on LTD from his job as of Sept 27/2022
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive, Sinus disorder
Clinical narrative: My husband went into the doctor, he has a good chance of having bronchitis, but was COVID-19 positive. I felt like a horrible case of sinus in my throat and through my head. It was not in my chest, just head and my throat. I did have a cough. I was COVID-19 positive. At my husband's doctor's visit, they gave me a Z-PAK and a steroid and continue my allergy medicine when I called for myself the next day. I did not feel the greatest for about a week.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Atelectasis, Blood cholesterol normal, Blood folate normal
Clinical narrative: Patient is a 79 y.o. male patient of MD with history of CLL, Colon cancer, C-dif, GERD, HLD  presented to Hospital with shortness of breath .   Acute hypoxic respiratory failure  Suspecting secondary to COVID-19 viral pneumonia  CXR shows faint patchy opacities in left mid to lower lung zone which may correspond to some subtle atelectasis or pneumonitis.  Started on Rocephin and Azithromycin for possible pneumonia however symptoms more consistent with viral etiology than bacterial especially given negative pro-cal. Urinary Ags and sputum culture negative D-dimer elevated. CTPA negative for PE but did show pulmonary HTN, patchy ground-glass infiltrates bilaterally with tiny bilateral pleural effusions.  Wean O2 requirements able Home O2 eval done today- qualified for 2L Management of COVID-19 listed below   Covid-19 viral pneumonia Date of onset of symptoms: 12/12/22 Symptoms present on admission: productive cough, chills, altered mental status Date of covid positive test: 12/12/22 - at home, repeat test positive Vaccination status: vaccinated Imaging: 7 faint patchy opacities in the left mid to lower lobes with some subtle atelectasis or pneumonitis Oxygen requirements on admission: 3L NC -> 4L Current oxygen requirements: 2L NC Medical therapy: Steroids x10 days. Out of time frame for Remdesivir Consultants following: None at this time Anticipated special isolation end date: TBD  Albuterol, steroids x5 days, and Tessalon Perles at discharge   Acute encephalopathy Suspecting secondary to hypoxia, underlying infection, and possible CVA TSH, B12, Folate all wnl Attempt to regulate sleep/wake cycle Resolved   Abnormal CT CT head shows low density areas in basal ganglia compatible with lacunar infarcts and/or dilated perivascular space. Low attenuation in left external capsule/subcortical insular white matter compatible with age indeterminate ischemic changes MRI brain showed chronic microvascular angiopathic changes Neuro consulted. Recommended starting ASA Neuro checks Q4H PT/OT/ST- HHC at discharge  History of CLL Patient is on Calquence BID which is non-formulary Continue Valcyclovir therapy Oncology consulted. Continue to hold Calquence/Acalabrutinib while admitted. Immunoglobulin levels shows decreased IgM of 33. Discussed with Dr. on day of discharge- does not need IVIG. Follow up with outpatient Oncologist when to resume Calquence/Acalabrutinib.   Hyperkalemia K 5.9 Hyperglycemia protocol with Ca-gluconate, Albuterol, and Lokelma Monitor   Hypernatremia Na 147 Resolved   DM, new onset Glucose also elevated due to steroids HbA1c 6.8 Recommend lifestyle changes Defer to PCP for further management   Hx of HLD Cholesterol panel: Cholesterol 194, TG 260, HDL 26, LDL 116 Recommend lifestyle changes Follow up with PCP for consideration for statin   Microcytic anemia Hb 12 with MV 96.5 No signs of bleeding Iron studies + ferritin pending- defer to PCP for follow up   Severe malnutrition POA Nutrition consulted   GERD  Continue Maalox PRN
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Blood triglycerides increased, COVID-19 pneumonia, Chest X-ray abnormal, Chills, Computerised tomogram head abnormal
Clinical narrative: Patient is a 79 y.o. male patient of MD with history of CLL, Colon cancer, C-dif, GERD, HLD  presented to Hospital with shortness of breath .   Acute hypoxic respiratory failure  Suspecting secondary to COVID-19 viral pneumonia  CXR shows faint patchy opacities in left mid to lower lung zone which may correspond to some subtle atelectasis or pneumonitis.  Started on Rocephin and Azithromycin for possible pneumonia however symptoms more consistent with viral etiology than bacterial especially given negative pro-cal. Urinary Ags and sputum culture negative D-dimer elevated. CTPA negative for PE but did show pulmonary HTN, patchy ground-glass infiltrates bilaterally with tiny bilateral pleural effusions.  Wean O2 requirements able Home O2 eval done today- qualified for 2L Management of COVID-19 listed below   Covid-19 viral pneumonia Date of onset of symptoms: 12/12/22 Symptoms present on admission: productive cough, chills, altered mental status Date of covid positive test: 12/12/22 - at home, repeat test positive Vaccination status: vaccinated Imaging: 7 faint patchy opacities in the left mid to lower lobes with some subtle atelectasis or pneumonitis Oxygen requirements on admission: 3L NC -> 4L Current oxygen requirements: 2L NC Medical therapy: Steroids x10 days. Out of time frame for Remdesivir Consultants following: None at this time Anticipated special isolation end date: TBD  Albuterol, steroids x5 days, and Tessalon Perles at discharge   Acute encephalopathy Suspecting secondary to hypoxia, underlying infection, and possible CVA TSH, B12, Folate all wnl Attempt to regulate sleep/wake cycle Resolved   Abnormal CT CT head shows low density areas in basal ganglia compatible with lacunar infarcts and/or dilated perivascular space. Low attenuation in left external capsule/subcortical insular white matter compatible with age indeterminate ischemic changes MRI brain showed chronic microvascular angiopathic changes Neuro consulted. Recommended starting ASA Neuro checks Q4H PT/OT/ST- HHC at discharge  History of CLL Patient is on Calquence BID which is non-formulary Continue Valcyclovir therapy Oncology consulted. Continue to hold Calquence/Acalabrutinib while admitted. Immunoglobulin levels shows decreased IgM of 33. Discussed with Dr. on day of discharge- does not need IVIG. Follow up with outpatient Oncologist when to resume Calquence/Acalabrutinib.   Hyperkalemia K 5.9 Hyperglycemia protocol with Ca-gluconate, Albuterol, and Lokelma Monitor   Hypernatremia Na 147 Resolved   DM, new onset Glucose also elevated due to steroids HbA1c 6.8 Recommend lifestyle changes Defer to PCP for further management   Hx of HLD Cholesterol panel: Cholesterol 194, TG 260, HDL 26, LDL 116 Recommend lifestyle changes Follow up with PCP for consideration for statin   Microcytic anemia Hb 12 with MV 96.5 No signs of bleeding Iron studies + ferritin pending- defer to PCP for follow up   Severe malnutrition POA Nutrition consulted   GERD  Continue Maalox PRN
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Encephalopathy, Enlarged cerebral perivascular spaces, Fibrin D dimer increased, Glycosylated haemoglobin increased
Clinical narrative: Patient is a 79 y.o. male patient of MD with history of CLL, Colon cancer, C-dif, GERD, HLD  presented to Hospital with shortness of breath .   Acute hypoxic respiratory failure  Suspecting secondary to COVID-19 viral pneumonia  CXR shows faint patchy opacities in left mid to lower lung zone which may correspond to some subtle atelectasis or pneumonitis.  Started on Rocephin and Azithromycin for possible pneumonia however symptoms more consistent with viral etiology than bacterial especially given negative pro-cal. Urinary Ags and sputum culture negative D-dimer elevated. CTPA negative for PE but did show pulmonary HTN, patchy ground-glass infiltrates bilaterally with tiny bilateral pleural effusions.  Wean O2 requirements able Home O2 eval done today- qualified for 2L Management of COVID-19 listed below   Covid-19 viral pneumonia Date of onset of symptoms: 12/12/22 Symptoms present on admission: productive cough, chills, altered mental status Date of covid positive test: 12/12/22 - at home, repeat test positive Vaccination status: vaccinated Imaging: 7 faint patchy opacities in the left mid to lower lobes with some subtle atelectasis or pneumonitis Oxygen requirements on admission: 3L NC -> 4L Current oxygen requirements: 2L NC Medical therapy: Steroids x10 days. Out of time frame for Remdesivir Consultants following: None at this time Anticipated special isolation end date: TBD  Albuterol, steroids x5 days, and Tessalon Perles at discharge   Acute encephalopathy Suspecting secondary to hypoxia, underlying infection, and possible CVA TSH, B12, Folate all wnl Attempt to regulate sleep/wake cycle Resolved   Abnormal CT CT head shows low density areas in basal ganglia compatible with lacunar infarcts and/or dilated perivascular space. Low attenuation in left external capsule/subcortical insular white matter compatible with age indeterminate ischemic changes MRI brain showed chronic microvascular angiopathic changes Neuro consulted. Recommended starting ASA Neuro checks Q4H PT/OT/ST- HHC at discharge  History of CLL Patient is on Calquence BID which is non-formulary Continue Valcyclovir therapy Oncology consulted. Continue to hold Calquence/Acalabrutinib while admitted. Immunoglobulin levels shows decreased IgM of 33. Discussed with Dr. on day of discharge- does not need IVIG. Follow up with outpatient Oncologist when to resume Calquence/Acalabrutinib.   Hyperkalemia K 5.9 Hyperglycemia protocol with Ca-gluconate, Albuterol, and Lokelma Monitor   Hypernatremia Na 147 Resolved   DM, new onset Glucose also elevated due to steroids HbA1c 6.8 Recommend lifestyle changes Defer to PCP for further management   Hx of HLD Cholesterol panel: Cholesterol 194, TG 260, HDL 26, LDL 116 Recommend lifestyle changes Follow up with PCP for consideration for statin   Microcytic anemia Hb 12 with MV 96.5 No signs of bleeding Iron studies + ferritin pending- defer to PCP for follow up   Severe malnutrition POA Nutrition consulted   GERD  Continue Maalox PRN